化学
兴奋剂
小分子
受体
肽
药理学
立体化学
生物化学
医学
作者
Guangxin Dong,Qijun Ye,Wenwen Li,Shaofeng Zhang,Zhenyu Yang,Rui Zhang,Deng Ta,Haiyan Li,Yong Zhang,Xiaojie Zhang,Shucheng He,Daoheng Zhou,Juan Zhang,Peng He,Yu Zhou,Yi Li
标识
DOI:10.1021/acs.jmedchem.5c00242
摘要
offers a promising therapeutic option for the management of T2D and obesity. Notably, it has successfully completed phase I clinical trials and is currently undergoing phase II clinical trials.
科研通智能强力驱动
Strongly Powered by AbleSci AI